Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study
Background and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH).Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to Au...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.826926/full |
_version_ | 1818965741547814912 |
---|---|
author | Xuan Yu Jiandong Chang Dezhi Zhang Qiang Lu Songsong Wu Kai Li |
author_facet | Xuan Yu Jiandong Chang Dezhi Zhang Qiang Lu Songsong Wu Kai Li |
author_sort | Xuan Yu |
collection | DOAJ |
description | Background and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH).Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to August 2021 at five medical centers in China was conducted.Results: A total of 53 patients were included (26 males and 27 females). The mean age was 35.1 ± 10.8 years. Sixty-five lesions (46 solitary cases and 7 cases with multiple lesions) were included, 70.8% (46/65) of which were located in the right liver lobe. The mean tumor length was 2.9 ± 1.5 cm. All patients successfully completed the ablation treatment. Immediate postoperative imaging showed that the primary technical success rate was 94.3% (50/53). Two patients underwent ablation 3 and 6 months after the primary ablation, and the secondary technical success rate was 100% (2/2). The incidence of complications was 3.8% (2/53). Imaging follow-up was conducted regularly after ablation, and no residual lesion enlargement or tumor recurrence was observed during the follow-up period. The technique efficacy rate was 98.1% (52/53).Conclusion: US-guided percutaneous thermal ablation is a safe and effective treatment for FNH of the liver. |
first_indexed | 2024-12-20T13:21:50Z |
format | Article |
id | doaj.art-d7d1b58441c14597a84ec8636f5d09a7 |
institution | Directory Open Access Journal |
issn | 2296-4185 |
language | English |
last_indexed | 2024-12-20T13:21:50Z |
publishDate | 2022-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Bioengineering and Biotechnology |
spelling | doaj.art-d7d1b58441c14597a84ec8636f5d09a72022-12-21T19:39:24ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852022-01-01910.3389/fbioe.2021.826926826926Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective StudyXuan Yu0Jiandong Chang1Dezhi Zhang2Qiang Lu3Songsong Wu4Kai Li5Department of Medical Ultrasonics, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong, ChinaDepartment of Ultrasound, Xiamen Chinese Medical Hospital, Fujian, ChinaDepartment of Ultrasound, The First Hospital of Jilin University, Jilin, ChinaDepartment of Ultrasound, West China Hospital, Sichuan, ChinaDepartment of Ultrasonography, Shengli Clinical Medical College of Fujian Medical University, Fujian, ChinaDepartment of Medical Ultrasonics, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong, ChinaBackground and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH).Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to August 2021 at five medical centers in China was conducted.Results: A total of 53 patients were included (26 males and 27 females). The mean age was 35.1 ± 10.8 years. Sixty-five lesions (46 solitary cases and 7 cases with multiple lesions) were included, 70.8% (46/65) of which were located in the right liver lobe. The mean tumor length was 2.9 ± 1.5 cm. All patients successfully completed the ablation treatment. Immediate postoperative imaging showed that the primary technical success rate was 94.3% (50/53). Two patients underwent ablation 3 and 6 months after the primary ablation, and the secondary technical success rate was 100% (2/2). The incidence of complications was 3.8% (2/53). Imaging follow-up was conducted regularly after ablation, and no residual lesion enlargement or tumor recurrence was observed during the follow-up period. The technique efficacy rate was 98.1% (52/53).Conclusion: US-guided percutaneous thermal ablation is a safe and effective treatment for FNH of the liver.https://www.frontiersin.org/articles/10.3389/fbioe.2021.826926/fullfocal nodular hyperplasiaultrasonographyradiofrequency ablationmicrowave ablationthermal ablation |
spellingShingle | Xuan Yu Jiandong Chang Dezhi Zhang Qiang Lu Songsong Wu Kai Li Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study Frontiers in Bioengineering and Biotechnology focal nodular hyperplasia ultrasonography radiofrequency ablation microwave ablation thermal ablation |
title | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_full | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_fullStr | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_full_unstemmed | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_short | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_sort | ultrasound guided percutaneous thermal ablation of hepatic focal nodular hyperplasia a multicenter retrospective study |
topic | focal nodular hyperplasia ultrasonography radiofrequency ablation microwave ablation thermal ablation |
url | https://www.frontiersin.org/articles/10.3389/fbioe.2021.826926/full |
work_keys_str_mv | AT xuanyu ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT jiandongchang ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT dezhizhang ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT qianglu ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT songsongwu ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT kaili ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy |